URO-1, a Greensboro medical device company specialized in prostate and soft tissue cancer diagnostics, is expanding its ...
TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...
— Clinical evidence continues to highlight TULSA’s ability to treat an unrivalled variety of patients with localized prostate cancer and/or BPH — “The various presentations made at AUA and other major ...
After skin cancer, prostate cancer is the most common cancer among men in the U.S., and 20% to 30% of men who beat it once will face a recurrence within five years. A new treatment, known as salvage ...
BEXAR COUNTY, Texas – Bexar County Judge Peter Sakai announced he will be taking a brief recovery period after a medical procedure over the holidays. In an online video, Sakai let the public know that ...